Pricing
  1. US-listed companies
  2. Bio Green Med Solution, Inc.
  3. Financials
  4. Stock-based compensation

Bio Green Med Solution, Inc.【BGMS】

Market cap
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 20241-59.81%
Dec 31, 20231-2.19%
Dec 31, 20222+30.16%
Dec 31, 20211+169.07%
Dec 31, 20200-7.73%
Dec 31, 20190+40.79%
Dec 31, 20180+24.44%
Dec 31, 20170-65.98%
Dec 31, 20161+4.97%
Dec 31, 20151-39.08%
Dec 31, 20141-93.81%
Dec 31, 201320+1.84%
Dec 31, 201219+2.00%
Dec 31, 201119

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)